Allarity Therapeutics Inc.
13F holders, Q2 2024 (June 30)9holders
$0.21avg. 13F price*
At the end of Q2 2024, 9 institutions reported holding Allarity Therapeutics Inc. in their 13F filings. The largest holders were Virtu Financial LLC ($56K), Geode Capital Management, LLC ($22K) and UBS Group AG ($9K).
- Company
- Allarity Therapeutics Inc.
- CUSIP
- 016744401
- Latest filing quarter
- Q2 2024
Total Exit/New Position Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $108K |
| Exits | 0 | $0 |
Ownership 9 holders
| Virtu Financial LLC | 0.00% | New | 265,338 | $56K |
| Geode Capital Management, LLC | 0.00% | New | 102,328 | $22K |
| UBS Group AG | 0.00% | New | 41,212 | $9K |
| Jump Financial, LLC | 0.00% | New | 38,795 | $8K |
| HRT Financial LP | 0.00% | New | 34,691 | $7K |
| Jane Street Group, LLC | 0.00% | New | 15,667 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 12,164 | $3K |
| Bank of America Corp. | 0.00% | New | 145 | $31 |
| Headlands Technologies LLC | 0.00% | New | 20 | $4 |
"% of holder's portfolio" is ALLARITY THERAPEUTICS INC's weight in each manager's 13F, not the share of Allarity Therapeutics Inc. the manager owns.